(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid

Catalog No. :
ACUWJA514
CAS No. :
116611-64-4
Molecular Formula :
C21H19N3O4
Molecular Weight :
377.40

IUPAC Name:(((9H-fluoren-9-yl)methoxy)carbonyl)-L-histidine

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$166.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid
IUPAC Name(((9H-fluoren-9-yl)methoxy)carbonyl)-L-histidine
MDL No.MFCD00190885
Molecular FormulaC21H19N3O4
Molecular Weight377.40
SMILESO=C(O)[C@H](CC1=CNC=N1)NC(OCC2C3=CC=CC=C3C4=CC=CC=C24)=O
InChI KeySIRPVCUJLVXZPW-IBGZPJMESA-N
SynonymAKOS037643742 | A-Fmoc -L-histidine | L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]- | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoicacid | (S)-2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYLAMINO)-3-(1H-IMIDAZOL-4-YL)PROPANOIC
CAS No.116611-64-4
PubChem CID7019075

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUWJA514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLDBK305 route compound structure diagram
    ACLDBK30571-00-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUWJA514 route product structure diagram
    ACUWJA514116611-64-4 In Stock
Inquiry

2. ACUWJA514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJXEY467 route compound structure diagram
    ACJXEY467160450-10-2 In Stock
  2. Then
  3. ACUWJA514 route product structure diagram
    ACUWJA514116611-64-4 In Stock
Inquiry

Comments (0)